[Edaily Reporter Park Jung-Soo ] #iA, Inc., a group under CUBE ENTERTAINMENT, INC., announced on the 7th that they are continuing their success immediately upon their comeback, sweeping domestic and international music charts with their 9th mini-album, "We made." Released on the 6th, “We made” is garnering significant attention as its tracks—including the title track “Gimme Dat Love”—have climbed to the top of major music charts. “Gimme Dat Love” reached No. 1 on the Bugs Real-Time Chart, No. 5 on Melon’s HOT 100 (30-day chart), and No. 1 on Melon’s Latest Chart (1-week chart). The pre-release track “Crow” also re-entered Melon’s HOT 100 and Latest Charts, while the tracks “Morning” and “Love Is Pain” also ranked high on the charts. The group’s success has extended overseas as well. “Gimme Dat Love” reached No. 1 on Tencent Music’s Korean chart in China, while “Morning” and “Love Is Pain” ranked No. 5 and No. 6, respectively. The album “We Made” took the No. 1 spot on QQ Music’s daily and weekly Best-Selling Digital Album (EP) charts and entered the iTunes Top Albums charts in 21 countries and regions, including No. 1 in Hong Kong. The music videos are also gaining global popularity. The “Gimme Dat Love” music video reached No. 1 on YouTube’s Music Video Trending Worldwide chart and ranked highly in 34 countries and regions, including South Korea, Australia, Germany, France, Russia, and the United Kingdom. It also ranked No. 2 on both QQ Music’s Overall Music Video Chart and its South Korea Chart. “Gimme Dat Love” is a song that captures the love felt in the moment when two people are strongly drawn to each other, and the group is connecting with global fans through a more pop-oriented sound and a summery vibe.
“Credit Checkpoint” is a column that assesses the credit rating risks of companies preparing to issue corporate bonds by examining their financial structure and cash flow. It evaluates a company’s sho…
Kim Dong-seon, President of Future Strategy at #Hanwha Machinery & Service Holdings (Hanwha M&S), is launching a tender offer for the company’s shares worth 128.5 billion won. Once this tender offer i…
ILDONG PHARM(249420)participated in a global pharmaceutical and biotech exhibition held in Milan, Italy, and engaged in partnering activities to expand its overseas business, including the export of a…